Geraint Phillips - Jan 3, 2023 Form 3 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Signature
/s/ Geraint Phillips
Stock symbol
BLFS
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
3
Date filed
1/9/2023, 06:00 PM
Next filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BLFS Common Stock 38.4K Jan 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BLFS Restricted Stock Award Jan 3, 2023 Common Stock 9.35K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount represented in Column 2 of Table I includes 24,969 shares of the Company's common stock, 4,047 shares of restricted stock granted on August 9, 2021 pursuant to the BioLife Solutions 2013 Performance Incentive Plan, as amended (the "Plan"), which vests in equal quarterly installments, and 9,346 shares of restricted stock granted on February 24, 2022 pursuant to the Plan which vests in equal quarterly installments.
F2 The restricted stock was granted pursuant to the Plan on February 24, 2022. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 3 of Table II based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.